tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Ratios

Compare
3 Followers

MaaT Pharma Ratios

FR:MAAT's free cash flow for Q2 2025 was €0.67. For the 2025 fiscal year, FR:MAAT's free cash flow was decreased by € and operating cash flow was €-6.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.22 1.90 2.78 4.57 10.05
Quick Ratio
2.21 1.89 2.76 4.57 10.04
Cash Ratio
0.94 1.38 2.11 3.82 9.21
Solvency Ratio
-0.74 -0.97 -0.84 -0.75 -0.92
Operating Cash Flow Ratio
-1.55 -1.51 -1.62 -1.37 -1.69
Short-Term Operating Cash Flow Coverage
-9.74 -10.23 -8.40 -4.54 -7.48
Net Current Asset Value
€ -5.01M€ -522.00K€ 9.53M€ 24.21M€ 37.70M
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.41 0.33 0.25 0.12
Debt-to-Equity Ratio
1.74 1.54 0.69 0.42 0.15
Debt-to-Capital Ratio
0.63 0.61 0.41 0.30 0.13
Long-Term Debt-to-Capital Ratio
0.43 0.43 0.21 0.23 0.09
Financial Leverage Ratio
5.89 3.72 2.10 1.67 1.24
Debt Service Coverage Ratio
-8.15 -7.55 -7.52 -4.55 -7.48
Interest Coverage Ratio
-31.13 -32.75 -49.61 -73.28 -73.50
Debt to Market Cap
0.08 0.10 0.10 0.14 0.15
Interest Debt Per Share
1.02 1.29 1.27 1.17 2.44
Net Debt to EBITDA
0.02 0.16 0.52 1.79 4.30
Profitability Margins
Gross Profit Margin
39.80%61.13%74.28%76.29%82.92%
EBIT Margin
-817.90%-871.77%-895.11%-947.97%-914.92%
EBITDA Margin
-793.13%-819.15%-886.00%-931.12%-896.30%
Operating Profit Margin
-823.99%-883.96%-895.11%-947.97%-914.92%
Pretax Profit Margin
-842.17%-1008.12%-884.96%-958.95%-927.88%
Net Profit Margin
-793.80%-898.76%-884.96%-969.93%-940.33%
Continuous Operations Profit Margin
-793.80%-898.76%-884.96%-958.95%-927.88%
Net Income Per EBT
94.26%89.15%100.00%101.14%101.34%
EBT Per EBIT
102.21%114.05%98.87%101.16%101.42%
Return on Assets (ROA)
-63.70%-75.07%-45.93%-31.01%-18.49%
Return on Equity (ROE)
-334.21%-279.64%-96.34%-51.73%-22.93%
Return on Capital Employed (ROCE)
-98.43%-118.75%-63.49%-38.18%-19.89%
Return on Invested Capital (ROIC)
-86.09%-93.63%-59.30%-35.63%-19.61%
Return on Tangible Assets
-67.65%-78.69%-47.41%-31.87%-18.80%
Earnings Yield
-28.22%-27.79%-24.86%-17.53%-28.21%
Efficiency Ratios
Receivables Turnover
0.22 2.12 0.43 0.34 0.41
Payables Turnover
0.23 0.14 0.09 0.08 4.88
Inventory Turnover
26.53 19.53 3.02 7.21 5.03
Fixed Asset Turnover
0.50 0.37 0.24 1.48 0.88
Asset Turnover
0.08 0.08 0.05 0.03 0.02
Working Capital Turnover Ratio
0.24 0.19 0.08 0.04 0.03
Cash Conversion Cycle
138.53 -2.39K -3.08K -3.72K 895.28
Days of Sales Outstanding
1.70K 171.83 845.99 1.08K 897.48
Days of Inventory Outstanding
13.76 18.69 121.03 50.60 72.56
Days of Payables Outstanding
1.57K 2.58K 4.04K 4.85K 74.76
Operating Cycle
1.71K 190.52 967.02 1.13K 970.04
Cash Flow Ratios
Operating Cash Flow Per Share
-1.64 -1.69 -1.64 -1.27 -3.27
Free Cash Flow Per Share
-1.69 -1.74 -1.74 -1.34 -3.37
CapEx Per Share
0.05 0.06 0.10 0.07 0.10
Free Cash Flow to Operating Cash Flow
1.03 1.03 1.06 1.05 1.03
Dividend Paid and CapEx Coverage Ratio
-31.67 -29.27 -17.08 -19.04 -33.32
Capital Expenditure Coverage Ratio
-31.67 -29.27 -17.08 -19.04 -33.32
Operating Cash Flow Coverage Ratio
-1.72 -1.38 -1.33 -1.11 -1.37
Operating Cash Flow to Sales Ratio
-6.32 -6.85 -8.38 -8.81 -8.16
Free Cash Flow Yield
-23.18%-21.92%-24.91%-16.77%-25.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.54 -3.60 -4.02 -5.71 -3.54
Price-to-Sales (P/S) Ratio
28.13 32.34 35.60 55.34 33.33
Price-to-Book (P/B) Ratio
13.30 10.06 3.88 2.95 0.81
Price-to-Free Cash Flow (P/FCF) Ratio
-4.31 -4.56 -4.01 -5.96 -3.97
Price-to-Operating Cash Flow Ratio
-4.45 -4.72 -4.25 -6.28 -4.09
Price-to-Earnings Growth (PEG) Ratio
-1.56 -0.13 -0.17 0.09 0.04
Price-to-Fair Value
13.30 10.06 3.88 2.95 0.81
Enterprise Value Multiple
-3.53 -3.79 -3.50 -4.15 0.59
Enterprise Value
109.70M 99.80M 69.12M 55.25M -5.10M
EV to EBITDA
-3.53 -3.79 -3.50 -4.15 0.59
EV to Sales
27.97 31.03 31.02 38.64 -5.25
EV to Free Cash Flow
-4.29 -4.38 -3.50 -4.16 0.62
EV to Operating Cash Flow
-4.42 -4.53 -3.70 -4.38 0.64
Tangible Book Value Per Share
0.36 0.66 1.68 2.59 16.09
Shareholders’ Equity Per Share
0.55 0.79 1.80 2.71 16.43
Tax and Other Ratios
Effective Tax Rate
0.06 0.11 0.00 -0.01 -0.01
Revenue Per Share
0.26 0.25 0.20 0.14 0.40
Net Income Per Share
-2.06 -2.21 -1.73 -1.40 -3.77
Tax Burden
0.94 0.89 1.00 1.01 1.01
Interest Burden
1.03 1.16 0.99 1.01 1.01
Research & Development to Revenue
7.49 8.54 9.11 10.12 9.41
SG&A to Revenue
1.73 0.83 1.06 1.02 1.20
Stock-Based Compensation to Revenue
0.00 0.48 0.39 0.46 0.81
Income Quality
0.80 0.76 0.95 0.92 0.88
Currency in EUR